US Stock MarketDetailed Quotes

CDLA Candela Medical

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 1 09:30 ET
0Market Cap0.00P/E (TTM)

Candela Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.45%-17.52M
-30.97M
Net income from continuing operations
-25.80%-43.89M
---34.89M
Operating gains losses
-38.36%810K
--1.31M
Depreciation and amortization
-7.65%16.66M
--18.04M
Deferred tax
-44.45%2.61M
--4.7M
Other non cash items
-563.64%-459K
--99K
Change In working capital
112.95%3.03M
---23.41M
-Change in receivables
240.15%23M
---16.41M
-Change in inventory
114.10%5.12M
---36.31M
-Change in prepaid assets
-168.05%-3.09M
--4.54M
-Change in payables and accrued expense
-224.90%-25.45M
--20.38M
-Change in other working capital
-21.22%3.46M
--4.39M
Cash from discontinued investing activities
Operating cash flow
43.45%-17.52M
---30.97M
Investing cash flow
Cash flow from continuing investing activities
42.32%-11.63M
-20.17M
Net PPE purchase and sale
42.32%-11.63M
---20.17M
Cash from discontinued investing activities
Investing cash flow
42.32%-11.63M
---20.17M
Financing cash flow
Cash flow from continuing financing activities
43.03%58.76M
41.08M
Net issuance payments of debt
869.82%58.97M
--6.08M
Net other financing activities
-100.59%-208K
--35M
Cash from discontinued financing activities
Financing cash flow
43.03%58.76M
--41.08M
Net cash flow
Beginning cash position
-26.91%27.5M
--37.63M
Current changes in cash
394.29%29.61M
---10.06M
Effect of exchange rate changes
2,497.01%1.61M
---67K
End cash Position
113.50%58.72M
--27.5M
Free cash flow
43.00%-29.15M
---51.14M
Currency Unit
USD
USD
Audit Opinions
Unqualified Opinion
--
(FY)Dec 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.45%-17.52M-30.97M
Net income from continuing operations -25.80%-43.89M---34.89M
Operating gains losses -38.36%810K--1.31M
Depreciation and amortization -7.65%16.66M--18.04M
Deferred tax -44.45%2.61M--4.7M
Other non cash items -563.64%-459K--99K
Change In working capital 112.95%3.03M---23.41M
-Change in receivables 240.15%23M---16.41M
-Change in inventory 114.10%5.12M---36.31M
-Change in prepaid assets -168.05%-3.09M--4.54M
-Change in payables and accrued expense -224.90%-25.45M--20.38M
-Change in other working capital -21.22%3.46M--4.39M
Cash from discontinued investing activities
Operating cash flow 43.45%-17.52M---30.97M
Investing cash flow
Cash flow from continuing investing activities 42.32%-11.63M-20.17M
Net PPE purchase and sale 42.32%-11.63M---20.17M
Cash from discontinued investing activities
Investing cash flow 42.32%-11.63M---20.17M
Financing cash flow
Cash flow from continuing financing activities 43.03%58.76M41.08M
Net issuance payments of debt 869.82%58.97M--6.08M
Net other financing activities -100.59%-208K--35M
Cash from discontinued financing activities
Financing cash flow 43.03%58.76M--41.08M
Net cash flow
Beginning cash position -26.91%27.5M--37.63M
Current changes in cash 394.29%29.61M---10.06M
Effect of exchange rate changes 2,497.01%1.61M---67K
End cash Position 113.50%58.72M--27.5M
Free cash flow 43.00%-29.15M---51.14M
Currency Unit USDUSD
Audit Opinions Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data